Mandate

Vinge has advised the Swedish state in connection with its sale of shares in SAS

October 13, 2016

Vinge has advised the Swedish state in connection with its sale of shares in SAS pursuant to a bookbuilding procedure performed on 12 October 2016.

In total, 23 million ordinary shares held by the Swedish and Norwegian governments were placed at a price of SEK 15.50 per share, equivalent to an aggregate value of approximately MSEK 357.  Following the transaction, the Swedish government holds 17.2 per cent of the ordinary shares and 17.1 per of the votes in SAS.

Vinge’s team consisted of partners Charlotte Levin and Eric Sjöman together with associates Amanda Knutsson and David Andersson.

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025